| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Biology of Reproduction, Vol 54, 287-293, Copyright © 1996 by Society for the Study of Reproduction
REVIEWS |
BS Katzenellenbogen
Department of Molecular and Integrative Physiology, Physiology, University of 61801-3704, USA.
Estrogens regulate the growth, differentiation, and functioning of diverse target tissues, both within and outside of the reproductive system. Most of the actions of estrogens appear to be exerted via the estrogen receptor (ER) of target cells, an intracellular receptor that is a member of a large superfamily of proteins that function as ligand- activated transcription factors, regulating the synthesis of specific RNAs and proteins. To understand how the ER discriminates between estrogen ligands, which activate the ER, and antiestrogen ligands, which fail to effectively activate the ER, we have generated and analyzed human estrogen receptors with mutations in the ER hormone binding domain. These studies provide evidence for the promoter- specific and cell-specific actions of the estrogen-occupied and antiestrogen-occupied and antiestrogen-occupied ER, highlight a regional dissociation of the hormone binding and transcription activation functions in domain E of the receptor, and indicate that some of the contact sites of estrogens and antiestrogens in the ER are likely different. In addition, multiple interactions among different cellular signaling pathways are involved in the regulation of gene expression and cell proliferation by the ER. In several cell types, protein kinase activators and some growth factors enhance the transcriptional activity of the ER. Cyclic AMP also alters the agonist/antagonist balance of some antiestrogens. Estrogens and, to a lesser extent, antiestrogens, as well as protein kinase activators and growth factors increase phosphorylation of the ER and possibly other proteins involved in the ER-specific response pathway, suggesting that changes in cellular phosphorylation state will be important in determining the biological activity of the ER and the effectiveness of antiestrogens as estrogen antagonists. The ER also has important interrelationships with the progesterone receptor (PR) system in modulation of biological responses. Liganded PR-A and PR-B can each suppress estradiol-stimulated ER activity, with the magnitude of repression dependent on the PR isoform, progestin ligand, promoter, and cell type. These findings underscore the mounting evidence for the importance of interactions between members of the steroid hormone receptor family.
This article has been cited by other articles:
|
|
 |
|
  D. Devost, M.-E. Carrier, and H. H. Zingg Oxytocin-Induced Activation of Eukaryotic Elongation Factor 2 in Myometrial Cells Is Mediated by Protein Kinase C Endocrinology, January 1, 2008; 149(1): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Pietras and D. C. Marquez-Garban Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers Clin. Cancer Res., August 15, 2007; 13(16): 4672 - 4676. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dong, Z. Zhang, and H. Takahara Estrogen-Enhanced Peptidylarginine Deiminase Type IV Gene (PADI4) Expression in MCF-7 Cells Is Mediated by Estrogen Receptor-{alpha}-Promoted Transfactors Activator Protein-1, Nuclear Factor-Y, and Sp1 Mol. Endocrinol., July 1, 2007; 21(7): 1617 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Gupta, D. Proia, O. Cingoz, J. Weremowicz, S. P. Naber, R. A. Weinberg, and C. Kuperwasser Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor-Negative Cancers Cancer Res., March 1, 2007; 67(5): 2062 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dhar, S. Banerjee, G. Dhar, K. Sengupta, and S. K. Banerjee Insulin-like Growth Factor-1 (IGF-1) Induces WISP-2/CCN5 via Multiple Molecular Cross-talks and Is Essential for Mitogenic Switch by IGF-1 Axis in Estrogen Receptor-Positive Breast Tumor Cells Cancer Res., February 15, 2007; 67(4): 1520 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Borras, J. Gambini, M. C. Gomez-Cabrera, J. Sastre, F. V. Pallardo, G. E. Mann, and J. Vina Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NF{kappa}B FASEB J, October 1, 2006; 20(12): 2136 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Zhu, G.-Z. Han, J.-Y. Shim, Y. Wen, and X.-R. Jiang Quantitative Structure-Activity Relationship of Various Endogenous Estrogen Metabolites for Human Estrogen Receptor {alpha} and {beta} Subtypes: Insights into the Structural Determinants Favoring a Differential Subtype Binding Endocrinology, September 1, 2006; 147(9): 4132 - 4150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Meyer, E. Haas, and M. Barton Gender Differences of Cardiovascular Disease: New Perspectives for Estrogen Receptor Signaling Hypertension, June 1, 2006; 47(6): 1019 - 1026. [Full Text] [PDF]
|
|
|
|
 |
|
 R Aguilar, C Bellido, J C Garrido-Gracia, R Alonso, and J E Sanchez-Criado Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries. Reproduction, April 1, 2006; 131(4): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Han, J. S. Heo, and Y. J. Lee Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1067 - C1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J.B. van Duijnhoven, P. H.M. Peeters, R. M.L. Warren, S. A. Bingham, A. G. Uitterlinden, P. A.H. van Noord, E. M. Monninkhof, D. E. Grobbee, and C. H. van Gils Influence of Estrogen Receptor {alpha} and Progesterone Receptor Polymorphisms on the Effects of Hormone Therapy on Mammographic Density. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 462 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, X. Xie, X. Zhu, J. Zhu, C. Hao, Q. Lu, L. Ding, Y. Liu, L. Zhou, Y. Liu, et al. Stimulatory Cross-talk between NFAT3 and Estrogen Receptor in Breast Cancer Cells J. Biol. Chem., December 30, 2005; 280(52): 43188 - 43197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Woclawek-Potocka, T. J. Acosta, A. Korzekwa, M. M. Bah, M. Shibaya, K. Okuda, and D. J. Skarzynski Phytoestrogens Modulate Prostaglandin Production in Bovine Endometrium: Cell Type Specificity and Intracellular Mechanisms Experimental Biology and Medicine, May 1, 2005; 230(5): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. DeNardo, H.-T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P. H. Brown Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes Mol. Endocrinol., February 1, 2005; 19(2): 362 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Barletta, P. Dhawan, and S. Christakos Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E598 - E608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leong, J. E. Riby, G. L. Firestone, and L. F. Bjeldanes Potent Ligand-Independent Estrogen Receptor Activation by 3,3'-Diindolylmethane Is Mediated by Cross Talk between the Protein Kinase A and Mitogen-Activated Protein Kinase Signaling Pathways Mol. Endocrinol., February 1, 2004; 18(2): 291 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Pratt and M. S. Kinch Ligand Binding Up-Regulates EphA2 Messenger RNA Through the Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Pathway Mol. Cancer Res., December 1, 2003; 1(14): 1070 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ding, J. Yan, J. Zhu, H. Zhong, Q. Lu, Z. Wang, C. Huang, and Q. Ye Ligand-independent activation of estrogen receptor {alpha} by XBP-1 Nucleic Acids Res., September 15, 2003; 31(18): 5266 - 5274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Wittmann, N. Wang, and M. M. Montano Identification of a Novel Inhibitor of Breast Cell Growth That Is Down-Regulated by Estrogens and Decreased in Breast Tumors Cancer Res., August 15, 2003; 63(16): 5151 - 5158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jiang, Y. E. Liu, A. Lu, A. Gupta, I. D. Goldberg, J. Liu, and Y. E. Shi Stimulation of Estrogen Receptor Signaling by {gamma} Synuclein Cancer Res., July 15, 2003; 63(14): 3899 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujita, Y. Kobayashi, O. Wada, Y. Tateishi, L. Kitada, Y. Yamamoto, H. Takashima, A. Murayama, T. Yano, T. Baba, et al. Full Activation of Estrogen Receptor {alpha} Activation Function-1 Induces Proliferation of Breast Cancer Cells J. Biol. Chem., July 11, 2003; 278(29): 26704 - 26714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lu, K. D. Miller, Y. Gokmen-Polar, M.-H. Jeng, and M. S. Kinch EphA2 Overexpression Decreases Estrogen Dependence and Tamoxifen Sensitivity Cancer Res., June 15, 2003; 63(12): 3425 - 3429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Boyan, V. L. Sylvia, T. Frambach, C. H. Lohmann, J. Dietl, D. D. Dean, and Z. Schwartz Estrogen-Dependent Rapid Activation of Protein Kinase C in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells and Estrogen Receptor-Negative HCC38 Cells Is Membrane-Mediated and Inhibited by Tamoxifen Endocrinology, May 1, 2003; 144(5): 1812 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response Clin. Cancer Res., January 1, 2003; 9(1): 447S - 454S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Pillai, J. M. Jones, and R. D. Koos Treatment of Rats with 17{beta}-Estradiol or Relaxin Rapidly Inhibits Uterine Estrogen Receptor {beta}1 and {beta}2 Messenger Ribonucleic Acid Levels Biol Reprod, December 1, 2002; 67(6): 1919 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. L. Hamelers, R. F. M. A. van Schaik, J. Sipkema, J. S. Sussenbach, and P. H. Steenbergh Insulin-like Growth Factor I Triggers Nuclear Accumulation of Cyclin D1 in MCF-7S Breast Cancer Cells J. Biol. Chem., November 27, 2002; 277(49): 47645 - 47652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Adeyinka, Y. Nui, T. Cherlet, L. Snell, P. H. Watson, and L. C. Murphy Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression Clin. Cancer Res., June 1, 2002; 8(6): 1747 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells Endocrinology, May 1, 2002; 143(5): 1872 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, O. Wada, M. Suzawa, Y. Yogiashi, T. Yano, S. Kato, and J. Yanagisawa The Tamoxifen-responsive Estrogen Receptor alpha Mutant D351Y Shows Reduced Tamoxifen-dependent Interaction with Corepressor Complexes J. Biol. Chem., November 9, 2001; 276(46): 42684 - 42691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Leong, G. L. Firestone, and L. F. Bjeldanes Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-{alpha} expression Carcinogenesis, November 1, 2001; 22(11): 1809 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Oliveira, K. Carnes, L. R. Franca, and R. A. Hess Infertility and Testicular Atrophy in the Antiestrogen-Treated Adult Male Rat Biol Reprod, September 1, 2001; 65(3): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Demay, M. De Monti, C. Tiffoche, C. Vaillant, and M. L. Thieulant Steroid-Independent Activation of ER by GnRH in Gonadotrope Pituitary Cells Endocrinology, August 1, 2001; 142(8): 3340 - 3347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. V. Martini and B. S. Katzenellenbogen Regulation of Prothymosin {alpha} Gene Expression by Estrogen in Estrogen Receptor-Containing Breast Cancer Cells via Upstream Half-Palindromic Estrogen Response Element Motifs Endocrinology, August 1, 2001; 142(8): 3493 - 3501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yang, S. J. Hyllner, and S. Christakos Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E162 - E170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guo, L. Savage, K. D. Sarge, and O.-K. Park-Sarge Gonadotropins Decrease Estrogen Receptor-{beta} Messenger Ribonucleic Acid Stability in Rat Granulosa Cells Endocrinology, June 1, 2001; 142(6): 2230 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Brinton Cellular and Molecular Mechanisms of Estrogen Regulation of Memory Function and Neuroprotection Against Alzheimer's Disease: Recent Insights and Remaining Challenges Learn. Mem., May 1, 2001; 8(3): 121 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. M. Benten, C. Stephan, M. Lieberherr, and F. Wunderlich Estradiol Signaling via Sequestrable Surface Receptors Endocrinology, April 1, 2001; 142(4): 1669 - 1677. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. O. Stemmer-Rachamimov, T. Wiederhold, G. P. Nielsen, M. James, D. Pinney-Michalowski, J. E. Roy, W. A. Cohen, V. Ramesh, and D. N. Louis NHE-RF, a Merlin-Interacting Protein, Is Primarily Expressed in Luminal Epithelia, Proliferative Endometrium, and Estrogen Receptor-Positive Breast Carcinomas Am. J. Pathol., January 1, 2001; 158(1): 57 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seth, K. L. Lunetta, D. W. Bell, H. Gray, S. M. Nasser, E. Rhei, C. M. Kaelin, D. J. Iglehart, J. R. Marks, J. E. Garber, et al. Phenol Sulfotransferases: Hormonal Regulation, Polymorphism, and Age of Onset of Breast Cancer Cancer Res., December 1, 2000; 60(24): 6859 - 6863. [Abstract] [Full Text]
|
|
|
|
 |
|
 Q. Meng, F. Yuan, I. D. Goldberg, E. M. Rosen, K. Auborn, and S. Fan Indole-3-Carbinol Is a Negative Regulator of Estrogen Receptor-{{alpha}} Signaling in Human Tumor Cells J. Nutr., December 1, 2000; 130(12): 2927 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871. [Abstract] [Full Text]
|
|
|
|
|
|
N. Danilovich, P. S. Babu, W. Xing, M. Gerdes, H. Krishnamurthy, and M. R. Sairam Estrogen Deficiency, Obesity, and Skeletal Abnormalities in Follicle-Stimulating Hormone Receptor Knockout (FORKO) Female Mice Endocrinology, November 1, 2000; 141(11): 4295 - 4308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. V. Martini, R. Delage-Mourroux, D. M. Kraichely, and B. S. Katzenellenbogen Prothymosin Alpha Selectively Enhances Estrogen Receptor Transcriptional Activity by Interacting with a Repressor of Estrogen Receptor Activity Mol. Cell. Biol., September 1, 2000; 20(17): 6224 - 6232. [Abstract] [Full Text]
|
|
|
|
|
|
S.-H. Hong and M. L. Privalsky The SMRT Corepressor Is Regulated by a MEK-1 Kinase Pathway: Inhibition of Corepressor Function Is Associated with SMRT Phosphorylation and Nuclear Export Mol. Cell. Biol., September 1, 2000; 20(17): 6612 - 6625. [Abstract] [Full Text]
|
|
|
|
|
|
T. Otsuki, O. Yamada, J. Kurebayashi, T. Moriya, H. Sakaguchi, H. Kunisue, K. Yata, M. Uno, Y. Yawata, and A. Ueki Estrogen Receptors in Human Myeloma Cells Cancer Res., March 1, 2000; 60(5): 1434 - 1441. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.A. Habiba, S.C. Bell, and F. Al-Azzawi The effect of hormone replacement therapy on the immunoreactive concentrations in the endometrium of oestrogen and progesterone receptor, heat shock protein 27, and human {beta}-lactoglobulin Hum. Reprod., January 1, 2000; 15(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Webb, P. Nguyen, C. Valentine, G. N. Lopez, G. R. Kwok, E. McInerney, B. S. Katzenellenbogen, E. Enmark, J.-A. Gustafsson, S. Nilsson, et al. The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions Mol. Endocrinol., October 1, 1999; 13(10): 1672 - 1685. [Abstract] [Full Text]
|
|
|
|
|
|
M. Campbell-Thompson, G. Y. Lauwers, K. K. Reyher, J. Cromwell, and K. T. Shiverick 17{beta}-Estradiol Modulates Gastroduodenal Preneoplastic Alterations in Rats Exposed to the Carcinogen N-Methyl-N'-Nitro-Nitrosoguanidine Endocrinology, October 1, 1999; 140(10): 4886 - 4894. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Rusa, N. J. Alkayed, B. J. Crain, R. J. Traystman, A. S. Kimes, E. D. London, J. A. Klaus, P. D. Hurn, and C. Iadecola 17{beta}-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals • Editorial Comment Stroke, August 1, 1999; 30(8): 1665 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Ediger, W. L. Kraus, E. J. Weinman, and B. S. Katzenellenbogen Estrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor Endocrinology, July 1, 1999; 140(7): 2976 - 2982. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. Tarleton, A. A. Wiley, and F. F. Bartol Endometrial Development and Adenogenesis in the Neonatal Pig: Effects of Estradiol Valerate and the Antiestrogen ICI 182,780 Biol Reprod, July 1, 1999; 61(1): 253 - 263. [Abstract] [Full Text]
|
|
|
|
|
|
G. Lazennec, J. L. Alcorn, and B. S. Katzenellenbogen Adenovirus-Mediated Delivery of a Dominant Negative Estrogen Receptor Gene Abrogates Estrogen-Stimulated Gene Expression and Breast Cancer Cell Proliferation Mol. Endocrinol., June 1, 1999; 13(6): 969 - 980. [Abstract] [Full Text]
|
|
|
|
|
|
P. V. N. Bodine, H. A. Harris, and B. S. Komm Suppression of Ligand-Dependent Estrogen Receptor Activity by Bone-Resorbing Cytokines in Human Osteoblasts Endocrinology, June 1, 1999; 140(6): 2439 - 2451. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fan, J. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg, et al. BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells Science, May 21, 1999; 284(5418): 1354 - 1356. [Abstract] [Full Text]
|
|
|
|
|
|
J.R. Malayer, J. Cheng, and V.M. Woods Estrogen Responses in Bovine Fetal Uterine Cells Involve Pathways Directed by Both Estrogen Response Element and Activator Protein-1 Biol Reprod, May 1, 1999; 60(5): 1204 - 1210. [Abstract] [Full Text]
|
|
|
|
|
|
S. T. Leung, D. C. Wathes, I. R. Young, and G. Jenkin Effect of Labor Induction on the Expression of Oxytocin Receptor, Cytochrome P450 Aromatase, and Estradiol Receptor in the Reproductive Tract of the Late-Pregnant Ewe Biol Reprod, April 1, 1999; 60(4): 814 - 820. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Sasano, T. Suzuki, Y. Matsuzaki, T. Fukaya, M. Endoh, H. Nagura, and M. Kimura Messenger Ribonucleic Acid in Situ Hybridization Analysis of Estrogen Receptors {alpha} and {beta} in Human Breast Carcinoma J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 781 - 785. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Roper, J. S. Griffith, C. R. Lyttle, R. W. Doerge, |
